Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer.

Fu R, Wang Y, Rehman I, Bedford E, Sharif S, Nguyen ND, Powell RT, Adams A, Liu W, Wang S, He W, Lu Y, Liu B, Shah PA, Ahnert JR, Chen T, Peng W, Stephan CC, Liu X, Bedford MT, Xu H

Open source

DOI: 10.3390/biom16081198
Published: 2026 Aug 17
Container: Biomolecules
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/biom16081198,
  title = {Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer.},
  author = {Fu R and Wang Y and Rehman I and Bedford E and Sharif S and Nguyen ND and Powell RT and Adams A and Liu W and Wang S and He W and Lu Y and Liu B and Shah PA and Ahnert JR and Chen T and Peng W and Stephan CC and Liu X and Bedford MT and Xu H},
  year = {2026},
  journal = {Biomolecules},
  doi = {10.3390/biom16081198},
  url = {https://doi.org/10.3390/biom16081198}
}

RIS

TY  - JOUR
TI  - Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer.
AU  - Fu R
AU  - Wang Y
AU  - Rehman I
AU  - Bedford E
AU  - Sharif S
AU  - Nguyen ND
AU  - Powell RT
AU  - Adams A
AU  - Liu W
AU  - Wang S
AU  - He W
AU  - Lu Y
AU  - Liu B
AU  - Shah PA
AU  - Ahnert JR
AU  - Chen T
AU  - Peng W
AU  - Stephan CC
AU  - Liu X
AU  - Bedford MT
AU  - Xu H
PY  - 2026
JO  - Biomolecules
DO  - 10.3390/biom16081198
UR  - https://doi.org/10.3390/biom16081198
ER  -

APA

R, F., Y, W., I, R., E, B., S, S., ND, N., RT, P., A, A., W, L., S, W., W, H., Y, L., B, L., PA, S., JR, A., T, C., W, P., CC, S., X, L., MT, B., & H, X. (2026). Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer.. Biomolecules. https://doi.org/10.3390/biom16081198

Source records

pubmed · retrieved 2026-09-25T07:22:27.648Z